Inventor · disambiguated record
Joel C. Barrish
Also filed as: BARRISH JOEL · BARRISH JOEL C · BARRISH JOEL CHARLES
50 granted patents·5 pending applications·2,070 citations·filing 1989–2023
99Inventor score
Top patents by PatentIndex Score
55 records- 0198US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
- 0298US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
- 0398US6670357B2Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 30, 2003·137 cites·24 claims
- 0498US6596746B1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 22, 2003·257 cites·49 claims
- 0598US6043265AIsoxazolyl endothelin antagonistsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Mar 28, 2000·402 cites·55 claims
- 0697US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
- 0797US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
- 0897US11053253B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·16 cites·9 claims
- 0997US7153856B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·38 cites·8 claims
- 1097US5100889A7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseaseSQUIBB & SONS INC·Filed 1990·Granted Mar 31, 1992·88 cites·41 claims
- 1196US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
- 1296US11718626B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
- 1396US9382219B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 5, 2016·17 cites·11 claims
- 1496US6706717B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 16, 2004·73 cites·11 claims
- 1594US7125875B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 24, 2006·74 cites·27 claims
- 1694US5760038ASubstituted biphenyl sulfonamide endothelin antagonistsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Jun 2, 1998·81 cites·26 claims
- 1793US7241781B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jul 10, 2007·17 cites·16 claims
- 1893US5990109AHeterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Nov 23, 1999·163 cites·42 claims
- 1993US5846990ASubstituted biphenyl isoxazole sulfonamidesBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Dec 8, 1998·132 cites·31 claims
- 2092US6635626B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Oct 21, 2003·55 cites·16 claims
- 2192US5481011AProcess for preparing N-protected amino acid α-halomethyl ketones and alcohols from N-protected amino acid estersBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jan 2, 1996·45 cites·16 claims
- 2290US7091223B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 15, 2006·21 cites·12 claims
- 2390US6979694B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 27, 2005·23 cites·11 claims
- 2489US8716323B2Cyclic protein tyrosine kinase inhibitorsDAS JAGABANDHU·Filed 2005·Granted May 6, 2014·9 cites·20 claims
- 2588US6271248B1Substituted biphenysulfonamide endothelin antagonistsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Aug 7, 2001·30 cites·25 claims
- 2686US6825355B2Benzothiazole protein trosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 30, 2004·27 cites·2 claims
- 2785US5153327A7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseaseSQUIBB & SONS INC·Filed 1991·Granted Oct 6, 1992·26 cites·4 claims
- 2884US5780473ASubstituted biphenyl sulfonamide endothelin antagonistsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Jul 14, 1998·34 cites·34 claims
- 2984US5202486ATetrahydroethanonaphthaleneamine derivativesSQUIBB & SONS INC·Filed 1990·Granted Apr 13, 1993·23 cites·8 claims
- 3083US8993567B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 31, 2015·3 cites·12 claims
- 3183US6239133B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 29, 2001·12 cites·18 claims
- 3283US5559256AAminediol protease inhibitorsSQUIBB & SONS INC·Filed 1993·Granted Sep 24, 1996·42 cites·18 claims
- 3381US12297205B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·15 claims
- 3477US4902684ABenzazepine and benzothiazepine derivativesSQUIBB & SONS INC·Filed 1989·Granted Feb 20, 1990·13 cites·43 claims
- 3576US6080774ASubstituted biphenylsulfonamide endothelin antagonistsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Jun 27, 2000·37 cites·10 claims
- 3676US5939446AHeteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonistsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Aug 17, 1999·18 cites·18 claims
- 3774US6235740B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted May 22, 2001·45 cites·41 claims
- 3872US2019210986A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3969US6958336B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 25, 2005·2 cites·17 claims
- 4069US6956045B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 18, 2005·2 cites·17 claims
- 4169US6953795B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 11, 2005·2 cites·17 claims
- 4267US6420403B1Inhibitors of IMPDH enzymeFiled 1999·Granted Jul 16, 2002·11 cites·23 claims
- 4367US5492910ARetrocarbamate protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Feb 20, 1996·9 cites·10 claims
- 4467US2018016247A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4566US7037926B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 2, 2006·1 cites·17 claims
- 4665US2009227567A1Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 4764US2016264537A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 4859US4952692ABenzazepine derivativesSQUIBB & SONS INC·Filed 1989·Granted Aug 28, 1990·9 cites·24 claims
- 4956US5276026ATetrahydroethanonaphthaleneamine derivativesSQUIBB & SONS INC·Filed 1993·Granted Jan 4, 1994·4 cites·5 claims
- 5054US2004229877A1Methods of treating p38 kinase-associated conditions with pyrrolotriazine compoundsFiled 2003·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joel C. Barrish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →